In a breakthrough that can reshape the treatment of internal injuries, scientists have created a swallowable printer that can ...
The global Phase 3 MOTION study (NCT05059262) aims to evaluate the efficacy and safety of vimseltinib for the treatment of TGCT in cases where surgical removal of the tumor is not an option.
With statins altering the liver’s natural function, and alcohol needing to be metabolised, Dr Guttmann says that having too ...
A functional medicine expert explains how looking at the root cause, not just symptoms, can help where conventional medicine ...
Doctors warn that even small festive indulgences can stress your liver. Experts share science-backed tips to drink ...
MedPage Today on MSN
Gene Therapy Shows Lasting Benefit for Children With Rare Disorder
For children born with severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), an investigational ...
The European Medicines Agency (EMA) has recommended granting marketing authorization in the EU for brensocatib (Brinsupri, ...
5hon MSN
Side effects of consuming too much dairy: What happens when you overdo milk, cheese, and yoghurt
Dairy products offer nutrients but overconsumption poses health risks. Excessive intake can cause digestive upset, bloating, ...
Autologous CD34+ hematopoietic stem-cell lentiviral gene therapy shows sustained clinical efficacy for severe combined ...
Explore how Pin1 inhibitors function as antivirals for herpes simplex virus, presenting a new avenue for HSV-1 therapy.
In a surprising discovery, MIT scientists found tiny loops in the genomes of dividing cells. Enabled by a high-resolution ...
News Medical on MSN
Pin1 inhibitors could reduce or stop outbreaks of herpes simplex virus 1
A class of antivirals called Pin1 inhibitors could reduce or stop outbreaks of herpes simplex virus 1 (HSV-1), the common infection behind oral herpes, according to new research published in Antiviral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results